Anzupgo 20 mg/g cream
Sponsors
Region Midtjylland, Gentofte Hospital
Conditions
Cutaneous T-cell lymphoma (CTCL)
Mycosis fungoidesVitiligo
Phase 2
Open-label proof-of-concept trial of topical delgocitinib in patients with facial vitiligo
Not yet recruitingCTIS2025-523635-19-00
Target: 12Updated: 2026-01-12
An Investigator-Initiated, Descriptive, Proof-of-Concept, Open-Label Pilot Study Focusing on Topical JAK Inhibition as a Novel Treatment of Cutaneous T-Cell Lymphoma
Not yet recruitingCTIS2025-523472-23-01
Target: 15Updated: 2026-08-10